Last reviewed · How we verify

NCT03419546

Clinical Validation Trial of a Single-use Bronchoscope (Ambu® aScope ™ 4)

Completed Last updated 18 October 2018
What this trial tests

trial in Bronchoscopy in 216 participants. Completed in 31 August 2018.

Timeline
1 March 2018
Primary endpoint
31 August 2018
31 August 2018

Quick facts

Lead sponsorInstituto de Investigación Sanitaria de la Fundación Jiménez Díaz
StatusCompleted
Study typeOBSERVATIONAL
Enrollment216
Start date1 March 2018
Primary completion31 August 2018
Estimated completion31 August 2018
Sites1 location across Spain

Conditions studied

Sponsor

Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz — full company profile →

Who can join

18 and older, any sex, with Bronchoscopy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to evaluate the usefulness of the new Ambu® aScope ™ 4 bronchoscope, in the usual practice of low complexity diagnostic bronchoscopy managed by bronchoscopists who meet the minimum training requirements (having performed 100 supervised procedures \[ 10\]) and maintenance of competition (with more than 25 bronchoscopies per year \[10\]).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Bronchoscopy

Currently open trials in the same condition.

Other Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03419546.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing